A citation-based method for searching scientific literature

S Rubler, J Dlugash, Y Z Yuceoglu, T Kumral, A W Branwood, A Grishman. Am J Cardiol 1972
Times Cited: 1168







List of co-cited articles
1276 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Diabetic Cardiomyopathy: An Update of Mechanisms Contributing to This Clinical Entity.
Guanghong Jia, Michael A Hill, James R Sowers. Circ Res 2018
538
47

Role of diabetes in congestive heart failure: the Framingham study.
W B Kannel, M Hjortland, W P Castelli. Am J Cardiol 1974
27

Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes.
Bernard Zinman, Christoph Wanner, John M Lachin, David Fitchett, Erich Bluhmki, Stefan Hantel, Michaela Mattheus, Theresa Devins, Odd Erik Johansen, Hans J Woerle,[...]. N Engl J Med 2015
23

Insulin resistance and hyperinsulinaemia in diabetic cardiomyopathy.
Guanghong Jia, Vincent G DeMarco, James R Sowers. Nat Rev Endocrinol 2016
335
21

Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction.
John J V McMurray, Scott D Solomon, Silvio E Inzucchi, Lars Køber, Mikhail N Kosiborod, Felipe A Martinez, Piotr Ponikowski, Marc S Sabatine, Inder S Anand, Jan Bělohlávek,[...]. N Engl J Med 2019
18

Molecular mechanisms of diabetic cardiomyopathy.
Heiko Bugger, E Dale Abel. Diabetologia 2014
469
18

Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes.
Stephen D Wiviott, Itamar Raz, Marc P Bonaca, Ofri Mosenzon, Eri T Kato, Avivit Cahn, Michael G Silverman, Thomas A Zelniker, Julia F Kuder, Sabina A Murphy,[...]. N Engl J Med 2019
17

Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes.
Bruce Neal, Vlado Perkovic, Kenneth W Mahaffey, Dick de Zeeuw, Greg Fulcher, Ngozi Erondu, Wayne Shaw, Gordon Law, Mehul Desai, David R Matthews. N Engl J Med 2017
17

Diabetic cardiomyopathy: a hyperglycaemia- and insulin-resistance-induced heart disease.
Guanghong Jia, Adam Whaley-Connell, James R Sowers. Diabetologia 2018
244
13

Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure.
Milton Packer, Stefan D Anker, Javed Butler, Gerasimos Filippatos, Stuart J Pocock, Peter Carson, James Januzzi, Subodh Verma, Hiroyuki Tsutsui, Martina Brueckmann,[...]. N Engl J Med 2020
986
13

Diabetic cardiomyopathy: mechanisms and new treatment strategies targeting antioxidant signaling pathways.
Karina Huynh, Bianca C Bernardo, Julie R McMullen, Rebecca H Ritchie. Pharmacol Ther 2014
326
13

Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes.
Steven P Marso, Gilbert H Daniels, Kirstine Brown-Frandsen, Peter Kristensen, Johannes F E Mann, Michael A Nauck, Steven E Nissen, Stuart Pocock, Neil R Poulter, Lasse S Ravn,[...]. N Engl J Med 2016
12


Myocardial cell death in human diabetes.
A Frustaci, J Kajstura, C Chimenti, I Jakoniuk, A Leri, A Maseri, B Nadal-Ginard, P Anversa. Circ Res 2000
605
12

Basic Mechanisms of Diabetic Heart Disease.
Rebecca H Ritchie, E Dale Abel. Circ Res 2020
80
15

Mechanisms of diabetic cardiomyopathy and potential therapeutic strategies: preclinical and clinical evidence.
Yi Tan, Zhiguo Zhang, Chao Zheng, Kupper A Wintergerst, Bradley B Keller, Lu Cai. Nat Rev Cardiol 2020
125
12

Diabetic cardiomyopathy revisited.
Sihem Boudina, E Dale Abel. Circulation 2007
11

Diabetic Cardiomyopathy.
Wolfgang H Dillmann. Circ Res 2019
109
11

Impact of diabetes on outcomes in patients with low and preserved ejection fraction heart failure: an analysis of the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) programme.
Michael R MacDonald, Mark C Petrie, Fumi Varyani, Jan Ostergren, Eric L Michelson, James B Young, Scott D Solomon, Christopher B Granger, Karl Swedberg, Salim Yusuf,[...]. Eur Heart J 2008
386
10

Diabetic Cardiomyopathy: Does the Type of Diabetes Matter?
Maximilian E Hölscher, Christoph Bode, Heiko Bugger. Int J Mol Sci 2016
79
12

The incidence of congestive heart failure in type 2 diabetes: an update.
Gregory A Nichols, Christina M Gullion, Carol E Koro, Sara A Ephross, Jonathan B Brown. Diabetes Care 2004
486
10

Heart Failure in Type 2 Diabetes Mellitus.
Helena C Kenny, E Dale Abel. Circ Res 2019
168
10

Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th edition.
Pouya Saeedi, Inga Petersohn, Paraskevi Salpea, Belma Malanda, Suvi Karuranga, Nigel Unwin, Stephen Colagiuri, Leonor Guariguata, Ayesha A Motala, Katherine Ogurtsova,[...]. Diabetes Res Clin Pract 2019
10

Implications of Underlying Mechanisms for the Recognition and Management of Diabetic Cardiomyopathy.
Thomas H Marwick, Rebecca Ritchie, Jonathan E Shaw, David Kaye. J Am Coll Cardiol 2018
129
10

IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045.
N H Cho, J E Shaw, S Karuranga, Y Huang, J D da Rocha Fernandes, A W Ohlrogge, B Malanda. Diabetes Res Clin Pract 2018
10

Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes.
Jennifer B Green, M Angelyn Bethel, Paul W Armstrong, John B Buse, Samuel S Engel, Jyotsna Garg, Robert Josse, Keith D Kaufman, Joerg Koglin, Scott Korn,[...]. N Engl J Med 2015
9

Clinical and Echocardiographic Characteristics and Cardiovascular Outcomes According to Diabetes Status in Patients With Heart Failure and Preserved Ejection Fraction: A Report From the I-Preserve Trial (Irbesartan in Heart Failure With Preserved Ejection Fraction).
Søren L Kristensen, Ulrik M Mogensen, Pardeep S Jhund, Mark C Petrie, David Preiss, Sithu Win, Lars Køber, Robert S McKelvie, Michael R Zile, Inder S Anand,[...]. Circulation 2017
89
10

Effect of Empagliflozin on Left Ventricular Mass in Patients With Type 2 Diabetes Mellitus and Coronary Artery Disease: The EMPA-HEART CardioLink-6 Randomized Clinical Trial.
Subodh Verma, C David Mazer, Andrew T Yan, Tamique Mason, Vinay Garg, Hwee Teoh, Fei Zuo, Adrian Quan, Michael E Farkouh, David H Fitchett,[...]. Circulation 2019
200
9

Glycaemic control and incidence of heart failure in 20,985 patients with type 1 diabetes: an observational study.
Marcus Lind, Ioannis Bounias, Marita Olsson, Soffia Gudbjörnsdottir, Ann-Marie Svensson, Annika Rosengren. Lancet 2011
164
9

Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study.
I M Stratton, A I Adler, H A Neil, D R Matthews, S E Manley, C A Cull, D Hadden, R C Turner, R R Holman. BMJ 2000
9

Hyperglycemia-induced apoptosis in mouse myocardium: mitochondrial cytochrome C-mediated caspase-3 activation pathway.
Lu Cai, Wei Li, Guangwu Wang, Luping Guo, Youchun Jiang, Y James Kang. Diabetes 2002
489
9

Abnormal cardiac and skeletal muscle energy metabolism in patients with type 2 diabetes.
Michaela Scheuermann-Freestone, Per L Madsen, David Manners, Andrew M Blamire, Robin E Buckingham, Peter Styles, George K Radda, Stefan Neubauer, Kieran Clarke. Circulation 2003
363
9


NLRP3 gene silencing ameliorates diabetic cardiomyopathy in a type 2 diabetes rat model.
Beibei Luo, Bo Li, Wenke Wang, Xiangjuan Liu, Yanfei Xia, Cheng Zhang, Mingxiang Zhang, Yun Zhang, Fengshuang An. PLoS One 2014
196
9

Mitochondrial energetics in the heart in obesity-related diabetes: direct evidence for increased uncoupled respiration and activation of uncoupling proteins.
Sihem Boudina, Sandra Sena, Heather Theobald, Xiaoming Sheng, Jordan J Wright, Xia Xuan Hu, Salwa Aziz, Josie I Johnson, Heiko Bugger, Vlad G Zaha,[...]. Diabetes 2007
408
9

Contributions of inflammation and cardiac matrix metalloproteinase activity to cardiac failure in diabetic cardiomyopathy: the role of angiotensin type 1 receptor antagonism.
Dirk Westermann, Susanne Rutschow, Sebastian Jäger, Anne Linderer, Stefan Anker, Alexander Riad, Thomas Unger, Heinz-Peter Schultheiss, Matthias Pauschinger, Carsten Tschöpe. Diabetes 2007
187
9

Diabetic Cardiomyopathy: Current and Future Therapies. Beyond Glycemic Control.
Giulia Borghetti, Dirk von Lewinski, Deborah M Eaton, Harald Sourij, Steven R Houser, Markus Wallner. Front Physiol 2018
71
12

Prevalence of ventricular diastolic dysfunction in asymptomatic, normotensive patients with diabetes mellitus.
John K Boyer, Srihari Thanigaraj, Kenneth B Schechtman, Julio E Pérez. Am J Cardiol 2004
323
8

Impact of diabetes on cardiac structure and function: the strong heart study.
R B Devereux, M J Roman, M Paranicas, M J O'Grady, E T Lee, T K Welty, R R Fabsitz, D Robbins, E R Rhoades, B V Howard. Circulation 2000
634
8

2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC.
Piotr Ponikowski, Adriaan A Voors, Stefan D Anker, Héctor Bueno, John G F Cleland, Andrew J S Coats, Volkmar Falk, José Ramón González-Juanatey, Veli-Pekka Harjola, Ewa A Jankowska,[...]. Eur Heart J 2016
8

Type 2 diabetes mellitus and heart failure: a position statement from the Heart Failure Association of the European Society of Cardiology.
Petar M Seferović, Mark C Petrie, Gerasimos S Filippatos, Stefan D Anker, Giuseppe Rosano, Johann Bauersachs, Walter J Paulus, Michel Komajda, Francesco Cosentino, Rudolf A de Boer,[...]. Eur J Heart Fail 2018
241
8

Comparative safety and effectiveness of metformin in patients with diabetes mellitus and heart failure: systematic review of observational studies involving 34,000 patients.
Dean T Eurich, Daniala L Weir, Sumit R Majumdar, Ross T Tsuyuki, Jeffrey A Johnson, Lisa Tjosvold, Saskia E Vanderloo, Finlay A McAlister. Circ Heart Fail 2013
203
8


Mechanisms of [Ca2+]i transient decrease in cardiomyopathy of db/db type 2 diabetic mice.
Laetitia Pereira, Jan Matthes, Iris Schuster, Héctor H Valdivia, Stefan Herzig, Sylvain Richard, Ana M Gómez. Diabetes 2006
182
8

Improvement of cardiac functions by chronic metformin treatment is associated with enhanced cardiac autophagy in diabetic OVE26 mice.
Zhonglin Xie, Kai Lau, Bonnie Eby, Pedro Lozano, Chaoyong He, Becky Pennington, Hongliang Li, Shradha Rathi, Yunzhou Dong, Rong Tian,[...]. Diabetes 2011
346
8

Diabetic cardiomyopathy: evidence, mechanisms, and therapeutic implications.
Zhi You Fang, Johannes B Prins, Thomas H Marwick. Endocr Rev 2004
656
8


Heart failure and diabetes: metabolic alterations and therapeutic interventions: a state-of-the-art review from the Translational Research Committee of the Heart Failure Association-European Society of Cardiology.
Christoph Maack, Michael Lehrke, Johannes Backs, Frank R Heinzel, Jean-Sebastien Hulot, Nikolaus Marx, Walter J Paulus, Patrick Rossignol, Heinrich Taegtmeyer, Johann Bauersachs,[...]. Eur Heart J 2018
107
7

Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes.
Steven P Marso, Stephen C Bain, Agostino Consoli, Freddy G Eliaschewitz, Esteban Jódar, Lawrence A Leiter, Ildiko Lingvay, Julio Rosenstock, Jochen Seufert, Mark L Warren,[...]. N Engl J Med 2016
7

Empagliflozin decreases myocardial cytoplasmic Na+ through inhibition of the cardiac Na+/H+ exchanger in rats and rabbits.
Antonius Baartscheer, Cees A Schumacher, Rob C I Wüst, Jan W T Fiolet, Ger J M Stienen, Ruben Coronel, Coert J Zuurbier. Diabetologia 2017
291
7


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.